Nexien BioPharma focuses on developing innovative therapies for various medical conditions, leveraging advanced biopharmaceutical technologies. The company employs a proprietary platform that enhances the delivery and efficacy of therapeutic agents, particularly in the treatment of cancer and autoimmune diseases. Their approach includes the use of targeted drug delivery systems, which aim to improve the precision of treatment while minimizing side effects, thereby enhancing patient outcomes.

In addition to their drug delivery systems, Nexien BioPharma is engaged in the development of novel biologics and small molecules. Their research emphasizes the importance of understanding disease mechanisms at a molecular level, which informs the design of their therapeutic candidates. By integrating cutting-edge scientific research with their proprietary technologies, Nexien BioPharma aims to address unmet medical needs and advance the field of biopharmaceuticals.

United States

Researchers and Developers of Cannabinoid-Based Pharmaceuticals in Accordance with U.S. Food and Drug Administration (FDA) Pre-Clinical and Clinical Pathways

Nexien BioPharma

Company Details